Using “PET Response Criteria in Solid Tumors (PERCIST)” in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer
Condition(s):Esophageal CancerLast Updated:April 15, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Esophageal CancerLast Updated:April 15, 2014Unknown status
Condition(s):Esophageal Neoplasm; Esophageal DiseaseLast Updated:April 1, 2015Completed
Condition(s):Early Esophageal Cancer or Precancerous Lesions Treated With Endoscopic ResectionLast Updated:December 19, 2017Unknown status
Condition(s):Esophageal CancerLast Updated:April 10, 2023Recruiting
Condition(s):Esophageal Cancer; Amino Acid Transport DisorderLast Updated:August 12, 2016Unknown status
Condition(s):Esophageal CancerLast Updated:September 28, 2017Completed
Condition(s):Esophageal CancerLast Updated:November 5, 2020Unknown status
Condition(s):Esophageal Cancer; Gastric (Cardia, Body) CancerLast Updated:March 8, 2024Completed
Condition(s):Esophageal CancerLast Updated:August 9, 2022Completed
Condition(s):Stage II Esophageal Cancer; Stage III Esophageal CancerLast Updated:October 16, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.